Extreme Option Profits Chart of Day…Merck (MRK)

Keep an eye on  Merck (MRK).

The stock could see higher highs after noting it would submit its oral, antiviral pill to the US FDA for emergency use authorization. All after analysis shows the drug cut the risk of hospitalizations or death by nearly half in a late stage trial.

According to the study, 14.1% of those that received the placebo were either hospitalized or died after 29 days, as compared to the 7.3% that received the treatment. Also, according to an independent data committee, trial recruitment can stop thanks to positive results, says Barron’s.

Former US FDA Commissioner Dr. Scott Gottlieb even said, “This is a phenomenal result. This is a profound game-changer to have an oral pill that had this kind of effect, this magnitude of effect in patients who are at high-risk who are already symptomatic,” as quoted by CNBC.

This is just one of the opportunities we find quite often inside Extreme Option Profits. 


  • Takes LESS Than 10 Minutes a Week
  • Averaged 32.26% Gains in Weekly Income Over the Last Year
  • Made 1,677.96% Returns in the Last 12 Months